title: NF-κB p65 subunit DNA-binding activity: association with depleted antioxidant levels in breast carcinoma patients.
abstract: NF-κB is recognized as a redox-sensitive transcription factor and has been implicated in cellular response to oxidative stress. The study was designed to correlate the changes in antioxidant status with the levels of nuclear factor-κB (NF-κB) p65 subunit DNA-binding activity in relation to lymph node involvement, tumor size, and staging in breast carcinoma patients. Case control study comprised of 40 breast carcinoma patients along with 40 age- and sex-matched healthy subjects as controls. Levels of enzymatic/nonenzymatic antioxidants along with the trace elements were measured to study the antioxidant status in the study subjects. Levels of NF-κB p65 subunit DNA-binding activity was estimated by ELISA assay. The levels of enzymatic, nonenzymatic antioxidants, and trace elements were found to be significantly depleted in breast carcinoma patients in comparison to healthy controls suggesting significantly decreased levels of antioxidant activity in the breast carcinoma patients. Also, these results indicate that antioxidant levels decrease progressively with the advancement of stage and subsequent progression of disease. DNA-binding activity of NF-κB p65 subunit was higher in breast cancer patients in comparison to normal healthy controls, and the activity was found to increase with the advancement of disease. Significant correlation was observed between the DNA-binding activity of NF-κB p65 subunit and antioxidant status in the patients. The logistic regression analysis revealed decreased levels of antioxidants and increased level of DNA-binding activity of NF-κB p65 subunit were significantly associated with incidence of breast carcinoma. Depleted antioxidant status and increased level of DNA-binding activity of NF-κB p65 subunit thus point clearly of an association in relation to disease progression, clinical stage, and cytological grade in the pathophysiology of breast carcinoma.
authors.affiliation: Department of Biophysics, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, India.
authors.forename: Deepti
authors.initials: D
authors.lastname: Pande
authors.forename: Kanchan
authors.initials: K
authors.lastname: Karki
authors.forename: Reena
authors.initials: R
authors.lastname: Negi
authors.forename: Seema
authors.initials: S
authors.lastname: Khanna
authors.forename: Ranjana S
authors.initials: RS
authors.lastname: Khanna
authors.forename: H D
authors.initials: HD
authors.lastname: Khanna
mesh_terms: D000328:Adult; D000975:Antioxidants / Q000378:metabolism*; D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology; D016022:Case-Control Studies; D002374:Catalase / Q000378:metabolism; D004247:DNA / Q000378:metabolism*; D005260:Female; D005979:Glutathione Peroxidase / Q000378:metabolism; D006801:Humans; D016015:Logistic Models; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009367:Neoplasm Staging; D011485:Protein Binding; D013482:Superoxide Dismutase / Q000378:metabolism; D014131:Trace Elements / Q000378:metabolism; D051996:Transcription Factor RelA / Q000378:metabolism*
chemical_list: D000975:Antioxidants; D014131:Trace Elements; D051996:Transcription Factor RelA; D004247:DNA; D002374:Catalase; D005979:Glutathione Peroxidase; D013482:Superoxide Dismutase